Cargando…
Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes
BACKGROUND: With the wide application of preimplantation genetic testing (PGT) with trophectoderm (TE) biopsy, the safety of PGT has always been a concern. Since TE subsequently forms the placenta, it is speculated that the removal of these cells was associated with adverse obstetrical or neonatal o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985221/ https://www.ncbi.nlm.nih.gov/pubmed/36870973 http://dx.doi.org/10.1186/s12884-023-05466-z |
_version_ | 1784900906866704384 |
---|---|
author | Ji, Hui Zhang, Mian-Qiu Zhou, Qiao Zhang, Song Dong, Li Li, Xiu-Ling Zhao, Chun Ding, Hui Ling, Xiu-Feng |
author_facet | Ji, Hui Zhang, Mian-Qiu Zhou, Qiao Zhang, Song Dong, Li Li, Xiu-Ling Zhao, Chun Ding, Hui Ling, Xiu-Feng |
author_sort | Ji, Hui |
collection | PubMed |
description | BACKGROUND: With the wide application of preimplantation genetic testing (PGT) with trophectoderm (TE) biopsy, the safety of PGT has always been a concern. Since TE subsequently forms the placenta, it is speculated that the removal of these cells was associated with adverse obstetrical or neonatal outcomes after single frozen-thawed blastocyst transfer (FBT). Previous studies report contradictory findings with respect to TE biopsy and obstetric and neonatal outcomes. METHODS: We conducted a retrospective cohort study including 720 patients with singleton pregnancies from single FBT cycles who delivered at the same university-affiliated hospital between January 2019 and March 2022. The cohorts were divided into two groups: the PGT group (blastocysts with TE biopsy, n = 223) and the control group (blastocysts without biopsy, n = 497). The PGT group was matched with the control group by propensity score matching (PSM) analysis at a ratio of 1:2. The enrolled sample sizes in the two groups were 215 and 385, respectively. RESULTS: Patient demographic characteristics were comparable between the groups after PSM except for the proportion of recurrent pregnancy loss, which was significantly higher in the PGT cohort (31.2 vs. 4.2%, P < 0.001). Patients in the PGT group had significantly higher rates of gestational hypertension (6.0 vs. 2.6%, adjusted odds ratio (aOR) 2.91, 95% confidence interval (CI) 1.18–7.18, P = 0.020) and abnormal umbilical cord (13.0 vs. 7.8%, aOR 1.94, 95% CI 1.08–3.48, P = 0.026). However, the occurrence of premature rupture of membranes (PROM) (12.1 vs. 19.7%, aOR 0.59, 95% CI 0.35–0.99, P = 0.047) was significantly lower in biopsied blastocysts than in unbiopsied embryos. There were no significant differences in regard to other obstetric and neonatal outcomes between the two groups. CONCLUSIONS: Trophectoderm biopsy is a safe approach, as the neonatal outcomes from biopsied and unbiopsied embryos were comparable. Furthermore, PGT is associated with higher risks of gestational hypertension and abnormal umbilical cord but may have a protective effect on PROM. |
format | Online Article Text |
id | pubmed-9985221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99852212023-03-05 Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes Ji, Hui Zhang, Mian-Qiu Zhou, Qiao Zhang, Song Dong, Li Li, Xiu-Ling Zhao, Chun Ding, Hui Ling, Xiu-Feng BMC Pregnancy Childbirth Research BACKGROUND: With the wide application of preimplantation genetic testing (PGT) with trophectoderm (TE) biopsy, the safety of PGT has always been a concern. Since TE subsequently forms the placenta, it is speculated that the removal of these cells was associated with adverse obstetrical or neonatal outcomes after single frozen-thawed blastocyst transfer (FBT). Previous studies report contradictory findings with respect to TE biopsy and obstetric and neonatal outcomes. METHODS: We conducted a retrospective cohort study including 720 patients with singleton pregnancies from single FBT cycles who delivered at the same university-affiliated hospital between January 2019 and March 2022. The cohorts were divided into two groups: the PGT group (blastocysts with TE biopsy, n = 223) and the control group (blastocysts without biopsy, n = 497). The PGT group was matched with the control group by propensity score matching (PSM) analysis at a ratio of 1:2. The enrolled sample sizes in the two groups were 215 and 385, respectively. RESULTS: Patient demographic characteristics were comparable between the groups after PSM except for the proportion of recurrent pregnancy loss, which was significantly higher in the PGT cohort (31.2 vs. 4.2%, P < 0.001). Patients in the PGT group had significantly higher rates of gestational hypertension (6.0 vs. 2.6%, adjusted odds ratio (aOR) 2.91, 95% confidence interval (CI) 1.18–7.18, P = 0.020) and abnormal umbilical cord (13.0 vs. 7.8%, aOR 1.94, 95% CI 1.08–3.48, P = 0.026). However, the occurrence of premature rupture of membranes (PROM) (12.1 vs. 19.7%, aOR 0.59, 95% CI 0.35–0.99, P = 0.047) was significantly lower in biopsied blastocysts than in unbiopsied embryos. There were no significant differences in regard to other obstetric and neonatal outcomes between the two groups. CONCLUSIONS: Trophectoderm biopsy is a safe approach, as the neonatal outcomes from biopsied and unbiopsied embryos were comparable. Furthermore, PGT is associated with higher risks of gestational hypertension and abnormal umbilical cord but may have a protective effect on PROM. BioMed Central 2023-03-04 /pmc/articles/PMC9985221/ /pubmed/36870973 http://dx.doi.org/10.1186/s12884-023-05466-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ji, Hui Zhang, Mian-Qiu Zhou, Qiao Zhang, Song Dong, Li Li, Xiu-Ling Zhao, Chun Ding, Hui Ling, Xiu-Feng Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title | Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title_full | Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title_fullStr | Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title_full_unstemmed | Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title_short | Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
title_sort | trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985221/ https://www.ncbi.nlm.nih.gov/pubmed/36870973 http://dx.doi.org/10.1186/s12884-023-05466-z |
work_keys_str_mv | AT jihui trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT zhangmianqiu trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT zhouqiao trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT zhangsong trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT dongli trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT lixiuling trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT zhaochun trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT dinghui trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes AT lingxiufeng trophectodermbiopsyisassociatedwithadverseobstetricoutcomesratherthanneonataloutcomes |